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I. INTRODUCTION
Rhinoviruses are the most important common cold viruses to be discovered. The
name "6rhinovirus" reflects the prominent nasal involvement seen in infections with
these viruses. The large rhinovirus genus, which is a member of the picornavirus
family, contains over 100 different antigenic types. The discovery ofthe rhinoviruses
led to the realization that the common cold is an enormously complex syndrome.
The number of antigenically distinct rhinoviruses is so large that man can be
infected with a different rhinovirus each year and still not experience all of the
known types in a life time. Awareness of the complexity of the rhinovirus problem
has discouraged work on the development ofcommon cold vaccines and stimulated
interest in alternative approaches to control, such as chemoprophylaxis and envi-
ronmental measures. Although rhinoviruses are the best studied of the common
cold viruses, major gaps still remain in knowledge of their epidemiologic behavior.
The fundamental question of the number of antigenic types in existence is
unanswered, as is the related question ofthepossible occurrenceofantigenic drift of
serotypes.
II. HISTORICAL BACKGROUND
Another member of the picornavirus family, poliovirus, is known to have caused
disease in ancient times, so it is probable that rhinoviruses were in existence then
also. Colds were a nuisance in early civilization; then, as now, many useless remedies
were proposed for their treatment. In 400 B.C., Hippocrates noted that bleeding was
a frequently used, although worthless, treatment for colds. In the first century Pliny
the Younger prescribed . . . "kissing the hairy muzzle of a mouse" for colds. The
first sound epidemiologic knowledge about acute respiratory disease came with the
observations that sea voyagers and the inhabitants of isolated communities were
free of colds while not in contact with the outside world but developed colds when
such contact was reestablished. This led to theimportant conclusion that colds were
contagious.
Direct evidence of the infectious nature ofcolds came in 1914 from the volunteer
studies of Kruse who produced experimental colds in volunteers by intranasal
inoculation of cell-free filtrates of nasal secretions from persons with colds (97).
Similar experiments by Dochez et al. in 1930 confirmed that colds could be trans-
mitted by bacteria-free filtrates, suggesting that the responsible agents might be
viruses (38). At the same time, epidemiologic studies of acute respiratory disease in
populations had been started. Van Loghem measured the incidence ofcolds and ob-
'This article will subsequently appear as a chapter in a book entitled, "Virus Infections of Man: Epide-
miology and Control" (A. S. Evans, Ed.) to bepublished next year by Plenum Press, New York. Reprints
will not be available for this article.
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served their relationship to the seasons (168). Frost and associates made the per-
ceptive observation that common respiratory disease appearing during the months
of high prevalence, September to March, was composed of a series of short epi-
demics of irregular sequences and magnitude (57). This suggested that colds were
caused by a variety of different agents occurring in succession. In the 1940s and
1950s, long-term studies of colds in the home by Dingle, Badger, and Jordan yielded
precise information on attack rates by age and the importance of the home as a site
for transmission of respiratory infections (36). During the same period, a group at
the Common Cold Research Unit at Salisbury, England, headed by Andrewes and
later Tyrrell, was vigorously pursuing questions related to the etiology and epide-
miology of colds (1). Colds were successfully transmitted in volunteers using nasal
secretions which were later shown to contain rhinoviruses. Attempts at the time to
establish growth ofthe virus in artificial culture were unsuccessful.
Specific work on rhinoviruses began in 1956 when Pelon and Mogabgab (126) and
Price (135), working separately, reported the isolation of a new virus which subse-
quently was given the designation, rhinovirus lA. Within a few years Ketler, Ham-
parian, and Hilleman (93), using the highly sensitive human embryonic lung cells de-
veloped by Hayflick and Moorhead (74) isolated a number of different serologic
types, indicating that the rhinovirus group would not be small. Epidemiologic
studies conducted by Hamre and her associates (70) during the same period es-
tablished that rhinoviruses were responsible for a significant amount of acute
respiratory disease. Specific rhinovirus infection rates and the finding of recurrent
fall peaks of rhinovirus colds were reported from a longitudinal study by Gwaltney
et al. (62). In further studies of rhinovirus epidemiology by Monto(113) Dick et al.
(35), and Hendley et al. (77) the importance of the family setting and of school
children in particular in favoring rhinovirus transmission was demonstrated. Knight
et al. (28) noted the surprisingly small amount of virus necessary to initiate experi-
mental infections in volunteers. These workers also provided important information
on the pathogenesis (45) and immunology of rhinovirus infections (143). In 1967, a
collaborative program directed by Kapikian and Hamparian assigned numbers lA-
55 to the rhinovirus types then known (89). In 1971, a second phase of this program
added types 56 through 89 (90). Results of a third phase of the numbering program
currently in progress indicate that approximately 20 more rhinovirus types will be
added to the genus (71).
III. METHODOLOGY INVOLVED IN EPIDEMIOLOGIC ANALYSIS
A. Surveillance and Sampling
Three longitudinal studies of rhinovirus epidemiology have provided data on
rhinovirus attack rates. Surveillance of a population of young adults at an insurance
company in Charlottesville, Va., was conducted by collecting illness data on
symptom record cards in conjunction with weekly personal contact by a nurse-
epidemiologist (62). This nurse also collected samples at the time of illness. In ad-
dition, samples were obtained weekly from asymptomatic persons in a randomly se-
lected sample of the study population. In another study, families from
representative segments of the population in Tecumseh, Michigan were surveyed by
weekly telephone contact with a single household respondent who provided illness in-
formation for the family(119). In the third investigation, mothers of families with
newborn infants in a group health cooperative in Seattle, Washington recorded
illness information on their families and were visited biweekly for routine sampling
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(55). In the latter two studies, specimens were collected during home visits by a
nurse-epidemiologist when illness was reported to the study team by telephone.
B. Methods ofVirus Isolation and Propagation
Cell culture is the standard method for rhinovirus isolation and propagation.
Rhinoviruses grow best at temperatures of33-34°C under conditions ofmotion (87)
and will not grow in embryonated eggs or suckling mice. Most epidemiologic studies
have employed human embryonic lung cells, strains WI-26 and WI-38, or strains of
human embryonic lung cells originated by the laboratory conducting the study.
Rhinovirus cytopathic effect in WI-38 cell culture is readily discernible, making this
an easy system with which to work. The sensitivity ofWI-38 cells to rhinoviruses ap-
pears to be similar to that of the nasal mucosa of volunteers. Volunteer challenge
experiments comparing rhinovirus human and tissue culture infectious dose50, have
shown one human infectious dose50 to be equivalent to 0.03-0.75 tissue culture in-
fectious dose50, (45).
There are problems, however, with theuse ofhuman embryonic lung cell cultures.
The sensitivity to rhinovirus of strains ofdifferent origin may vary a hundredfold or
more for poorly understood reasons (8). Also, different lots ofthe same strain, such
as WI-38, may have unpredictable variations in rhinovirus sensitivity which are
unexplained (61). Interpretations of rhinovirus morbidity data must take these
variations into account since rates of rhinovirus associated illness are directly re-
lated to the sensitivity ofthe cell cultures used.
Rhinoviruses will grow in other cell lines and strains derived from human and pri-
mate tissues, including Rhesus monkey kidney, human embryonic kidney, and KB.
The sensitivity ofthese cells for rhinoviruses tends to be less consistent than that of
WI-38 cells. A strain of HeLa cells with enhanced sensitivity to rhinoviruses has
been developed and proven useful for propagation of antigen and for serologic
procedures (23). These M-HeLa cells have been used to grow rhinovirus harvests
with exceptionally high titers (109pfu/ml) (25) and to prepare large quantities ofan-
tigen in suspension cultures (162). All ofthe first 55 numbered rhinovirus types have
been plaqued using a method which employs HeLa cells and an agarose overlay
containing medium with added magnesium and DEAE-dextran (51).
The earlier division ofrhinoviruses into H and M strains on the basis ofgrowth in
cells of human or monkey origin has been of limited epidemiologic importance.
M strains tend to grow better in cell culture and, thus, were more easily recovered
with the less sensitive systems used in earlier studies (65). Consideration should be
given to the greater ease of recovery of M strains when evaluating epidemiologic
data, since this variable could result in over estimation of the importance of M
rhinoviruses. Recent work has shown that H strains can be adapted to grow in
monkey kidney cells, suggesting that the H and M strain division is not based on
majordifferences in the biologic properties ofrhinoviruses (41).
Organ cultures of fetal human trachea and other ciliated epithelium have been
used to isolate rhinoviruses which did not grow initially in cell culture (82,166).
Comparison ofthe sensitivity for rhinovirus isolation ofstandard cell culture and of
organ culture has failed to show clear superiority of the organ culture system (79);
both systems are necessary for optimal recovery of these viruses. Once isolated in
organ culture, rhinoviruses can be readily adapted to cell culture. The organ culture
strains have been found to be types which have also been recovered in cell culture.
Because ofthe limited supply offetal material, it has not been possible to use organ
culture systems in large epidemiologic studies.
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Experimental infection with human rhinoviruses have been produced in chim-
panzees (34) and gibbons (133), but attempts to infect smalllaboratory animals have
not been successful. Rhinoviruses have been isolated from cattle (112), and respira-
tory viruses with similar characteristics to human rhinovirus have been recovered
from cats (30) and horses (37).
C. Methods Used for Serologic Surveys and Antibody Measurements
The multiplicity of rhinovirus types and their relative immunologic specificity
have prevented the general use of serologic techniques for measuring infection rates.
Serologic study of infection rates is possible, however, when the types of rhinovirus
circulating in small populations, such as families, are known from viral cultures.
Testing for the presence ofrhinovirus antibody has been done with the neutralization
test, since this method was the only one available until recently. The neutralization
test has also been used to identify specific antigenic types ofvirus and to measure an-
tibody in human serum and nasal secretions.
In experimental rhinovirus infection, viral shedding was found to be more
sensitive than antibody response as a means of detecting infection (75) while in
studies of natural infections, either procedure alone identified only about two-thirds
of the diagnosed infections (4). In family studies, 20-40% oftotal infections were de-
tected only by serology in persons who had both testsperformed (35,77).
For typing rhinoviruses, hyperimmune rhinovirus antisera have been produced in
a number of animal species, including rabbits, guinea pigs, calves, goats, and ba-
boons. Some goat and calfantisera have contained cytotoxic substances which have
caused difficulties in the interpretation of neutralization test results (23). The large
number of rhinovirus serotypes has led to the use of antisera pools for serotype
identification. An efficient method of antisera pooling is the combinatorial method
(92). Serologic identifications of rhinoviruses in large epidemiologic studies can be
done with pooled antisera used in microneutralization systems (59,96).
The accepted standard for serologic identity of an unknown rhinovirus is neu-
tralization of virus concentrations ranging from 10-300 TCID50 by 20 units of anti-
body (87). For measuring neutralizing antibody in human serum and nasal washings,
it is necessary to use small doses ofvirus (3-30 TCID50) for the test to have satisfac-
tory sensitivity (45). Somewhat more sensitive plaque reduction methods of
measuring antibody have been developed (16) but have not been used extensively as
an epidemiologic tool.
Complement fixation tests with rhinoviruses have been reported (20,33) but have
not been useful as a method of collecting morbidity data. Recently, rhinoviruses
have been found to agglutinate sheep erythrocytes (155). The test holds promise as
another method of collecting epidemiologic data, although not all serologic types
show hemagglutination under the condition of pH and temperature which were
studied.
IV. CHARACTERISTICS OF VIRUS AFFECTING THE
EPIDEMIOLOGICAL PATTERN
A. Physical and Biochemical Characteristics
Rhinoviruses have physical and biochemical properties which put them in the
picornavirus family (Table IA) (156,170). This family also includes enterovirus and
calicivirus. While sharing basic properties with enteroviruses, such as size, shape,
nucleic acid composition, and ether-resistence, rhinoviruses differ in having a greater
buoyant density and a susceptibility to inactivation by exposure to an acid environ-
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TABLE 1
Characteristics of Rhinovirus
A. Physical and Biochemical
Size: 8.4 X 106 daltons (20-40 nm)
Shape: capsid with cubic symmetry with proposed structure of60 identical four-chain subunits
Nucleic Acid: single-stranded RNA of 2.6 ± 0.1 X 106 daltons
Ether: resistant
Acid: labile (pH 3-5)
Virus synthesis and maturation in cytoplasm
B. Biological
Optimal temperature ofgrowth 33-35°C and restriction ofgrowth at 370C
Inability to survive and replicate in the intestinal tract
Survival on skin and environmental surfaces
Two or more receptor families for host cells
C. Antigenic
Native antigenicity: type-specific (D-antigenicity)
100 or more numbered native antigenic types
Direct and indirect antigenic relationships between some native antigenic types demonstrable with
hyperimmune sera
Altered antigenicity (by heat or urea): cross reactive between types (C-antigenicity)
ment (144). The basis for acid lability remains unclear, although treatment with acid
results in the loss from thevirion ofthe smallest ofthe four size classes ofrhinovirus
polypeptides (95). Recent evidence suggests that rhinoviruses are structurally
similar to enteroviruses (105) and that the greater buoyant density of rhinoviruses
on a cesium chloride gradient relates to efficiency ofbinding of cesium ions and not
to a basic difference from enteroviruses (106). Rhinovirus gene and cleavage pat-
terns have been found similar to that ofpoliovirus (103). Thus, the sum ofevidence
on the physical and biochemical nature of rhinoviruses suggests that they and
enteroviruses are descended from a common ancestor. Similarity in physical nature
of the two groups may help explain similarities in epidemiologic behavior, i.e., in-
creased prevalence in late summer and fall and possible spread by direct contact
with infectious secretions.
B. Biological Characteristics
The biochemical basis for the optimal temperature range for rhinovirus growth is
unknown, but this property may be of major epidemiologic importance (Table 1B).
The temperature of nasal mucosa, 33-35°C, corresponds to the optimal
temperature for rhinovirus replication. At 37°C virus yields fall to 10% to 50% of
optimum (156,167). In natural infection in man, rhinovirus concentrations are
higher in nasal secretions than in pharyngeal secretions, saliva, or secretions ob-
tained by simulated coughs and sneezes (78). Attempts to isolate rhinovirus from
blood have not been successful (42,47) nor does rhinovirus survive and replicate in
the intestinal tract. Studies of rhinovirus survival in the gut suggest that the
temperature of 37°C may be a decisive factor in inhibiting growth, although gas-
trointestinal secetions and transit time may also have an adverse effect on virus sur-
vival (17). On the basis of these observations, it is tempting to speculate that one
reason for the different pathogenic and epidemiologic behavior ofenteroviruses and
rhinoviruses is the difference in the optimal temperature for growth of the two
groups ofviruses.
Rhinovirus receptors are insensitive to neuraminidase but are sensitive to
proteolytic enzymes. Studies using HeLa cell cultures have shown that rhinoviruses
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can be separated into at least two different groups on the basis of attachment
receptor sites on the cell surface (99).
C. Antigenic Characteristics
Rhinoviruses in their native state contain type specific surface antigens (Table
IC). On the basis of a collaborative program, they have been classified as serotypes
1-89, and subtype,IA (88,89,90). Further work on rhinovirus numbering is nearing
completion and approximately 20 moretypes will be added to the classification (71).
There are a large number of rhinovirusstrains which have been recovered in recent
epidemiologic studies which are not neutralized by antisera to the numbered types.
The criterion for the selection of numbered prototype viruses was the absence of
cross-neutralization with other prototype candidates using animal hyperimmune
antiserum at dilutions of 1:2 to 1:20 in a standard neutralization test. There was a
virtual absence of cross-reactions with the antisera which were used in the num-
bering program. Recent work with high titered hyperimmune antisera, discussed
below, has disclosed antigenic relationships among some of the numbered types
which were not discovered in the collaborative program. In spite of these findings,
discussed in the next paragraph, thelarge number ofantigenically different types of
rhinovirus is undoubtedly an important characteristic of the group, influencing
epidemiologic behavior and accounting for the frequency of rhinovirus colds.
In an early study, antigenic relationships among different rhinovirus types were
reported, usinghyperimmune bovine antisera in neutralization tests (50). The bovine
antisera were later recognized to contain anticellular antibody. When this antibody
was removed, the antigenic cross-reactions largely disappeared (22). More recently,
potent monotypic rabbit antisera have been used to demonstrate four reciprocal and
fiveone-way cross-reactions among 37 rhinovirus types studied (26). The cross-reac-
tions wereusually minor. A number ofthese relationships were indirect and were de-
monstrable only by primary immunization with one rhinovirus type followed by im-
munization with a different but related type.
Theimportance ofcross-reactions in immunity in man is currently unknown, and
the results of work in this area are contradictory. Neutralization tests carried out
with paired sera from patients have usually not shown significant cross-reactions
following natural rhinovirus infections (73). On the other hand, in a study of experi-
mental infections in volunteers, heterotypic antibody responses were relatively com-
mon after infection with some types (53).
The native antigenicity of rhinoviruses can be altered by experimental means.
Treatment at pH 5 at56°C or in 2 M urea produces virus particles which react in
immunodiffusion and complement fixation tests with heterologous types (101).
When the virus is in this C-antigenic state, which apparently results from a
configurational change which exposes normally hidden determinants, it is unable to
attach to cell receptors. This alteration in antigenicity, which also occurs after virus
attachment to host cells, may be animportant step in the initiation ofinfection (100)
but probably plays no role in immunity to infection.
V. DESCRIPTIVE EPIDEMIOLOGY
A. Incidence and Prevalence of Infection
1. Age andSex Specific Attack Rates
Rhinovirus infections are the most common of the acute respiratory infections
(24,65) and probably the most common of all acute infections of man. Infection
rates based on virus isolations from routine specimens from family members in
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TABLE 2
Rhinovirus Infection Rates
A
Calculated from surveillance and sampling of all persons-well and ill
Location Age (yr) Person-years of observation Infections per person-year
Seattle, WA (24) 0-1 144 1.21
2-5 135 0.54
6-9 22 0.55
Mothers 208 0.20
All ages 510 0.59
Chicago, IL (69) 19-32 466 0.74a
Charlottesville, VA (62) 16-45 500 0.77b
B
Calculated from surveillance and sampling ofpersons with colds
Age Person-years No. resp. illness No. rhinovirus RI
Location (yr) of observation per person-year per person-year
Tecumseh, MI (120) <1 726 6.1 0.58'
1-4 3,516 5.2 0.50
5-9 5,064 3.5 0.33
10-19 6,228 2.5 0.24
20-29 3,786 2.75 0.26
30-49 8,394 2.0 0.19
50+ 1,716 1.45 0.14
All ages 29,430 3.0 0.29
Males:
Charlottesville, VA (62, 65) 16-24 240 2.2 0.51d
25-34 204 2.1 0.50
35-44 i11 2.3 0.54
45+ 24 2.2 0.51
All males 579 2.2 0.51
Females:
16-24 477 2.6 0.60
25-34 237 2.1 0.49
34-44 84 2.1 0.49
45+ 24 1.3 0.31
All females 822 2.4 0.55
All persons 1,401 2.3 0.53
aRhinovirus isolation percentages for well and ill persons 1.5% and 25.4%, respectively; sampling in-
terval of well persons 6 wk; data collected over four periods of 9 mo and adjusted to annual rates.
bRhinovirus isolation percentages for well and ill persons 2.1% and 23.3%, respectively; sampling in-
terval ofwell persons arbitrarily adjusted to 6 wk. Data collected over 1 yr.
cAll rates calculated using rhinovirus isolation percentage of 9.6%.
dAll rates calculated using rhinovirus isolation percentage of 23.3% (observed: 22.9% in males;
23.6% in females).
Seattle with and without symptoms were 0.59 per person-year (Table 2A). Rates in
this population ranged from 1.21 in the0-1 year agegroup to 0.20 in mothers; values
were intermediate in children 2-9 yr of age. Similar data collected from medical
students in Chicago (69) and insurance company employees in Charlottesville (62,
65)gave rhinovirus infection rates of0.74 and 0.77 per person-year, respectively.
True rhinovirus infection rates are probably higher than reported, since currently
available rhinovirus culture methods lack optimal sensitivity (see Section III). The
overall rhinovirus infection rates of 0.74 and 0.77 per person-year in Chicago and
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Charlottesville, respectively, are probably minimum values for the true incidence of
rhinovirus infections in young adults. Adjustment of the rates for young adults in
Chicago and Charlottesville to the consistent trend towards higher rates seen in
children gives projected rhinovirus infection rates in young children ofup to 1.5 per
person-year. Ofparticular interest was the slight increase in incidence ofrhinovirus
infections in young adults, 20-29 years, in the Michigan population and the in-
creased incidence in females in the 16-24 age group in the Charlottesville popu-
lation. These findings may relate to the importance of young children in
disseminating rhinovirus in the home, particularly to mothers. This is discussed
below in relation to rhinovirus infection in the family.
Rhinovirus illness rates have been measured in long-term studies of families and
insurance company workers. In Tecumseh the rhinovirus illness rate for all ages
was 0.29 per person-year (120). Rates ranged from 0.58 for infants less than one
year to 0.14 for adults over the age of50 (Table 2B). Rates declined proportionately
with increasing age. Data collected from the insurance company population of
young adults yielded rhinovirus illness rates of 0.53 (62). Rates for males and fe-
males derived from this study were 0.51 and 0.55, respectively. The higher rates in
females reflected a greater incidence of total colds in females and not an increased
incidence of rhinovirus recovery from females, since the rhinovirus isolation
percentages from males and females were not different. The reason for the
differences in rhinovirus illness rates in these studies is not clear but may relate to
variables, such as the methods of surveillance, criteria used in counting colds, and
varying sensitivities ofthe cell cultures used for virus recovery.
2. Prevalence ofAntibody and Geographic Distribution
Studies of the prevalence of rhinovirus antibody support the conclusion that
rhinovirus infections begin in early childhood and continue into adult life (Fig. 1).
50-
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FIG. 1. Distribution of neutralizing antibody in human sera according to age. Ninety-five sera were
tested at 1:4 dilution vs RV types IA-55. The vertical bars represent the standard error of the mean.
(With permission ofHamparian (72).)
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FIG. 2. Percent ofhuman sera with neutralizing antibody to rhinovirus type IA-55. Ninety-five sera were
tested at a 1:4 dilution. (With permission ofHamparian (72).)
Antibody to the various rhinovirus types begins to appear at an early age and in-
creases in prevalence throughout childhood and adolescence (117,159,165). The
prevalence of antibody reaches a peak in young adults (mean percent positive-60%)
probably reflecting the effect of exposure to young children in the home (72). Anti-
body prevalence then declines slightly to a level (mean percent positive-40-50%)
which persists throughout adulthood. Studies of antibody in sera collected serially
from the same individual show persistence ofantibody at relatively stable levels for
years (159). The mechanisms by which rhinovirus serum antibody levels persist are
unknown and could include inherent stability ofantibody formed initially and/or re-
current antigenic stimulation from the same or related types. The slight decrease in
prevalence of antibody after the early adult peak (Fig. 1) suggests that a decline in
antibody occurs when viral exposure is lessened. Limited work has also shown that
artifically induced neutralizing antibody in nasal secretions may persist for at least
330days following intranasal vaccination (11).
Information is also available on the prevalence of serum neutralizing antibody in
adults to each ofthe different serotypes, lA-55. In the groups studied, antibody was
present to all of the types tested (Fig. 2) (72). The prevalence of antibody ranged
from a low of 11% to a high of94%, and there was no sharp dividing point between
types associated with high and low antibody prevalence. It is ofinterest that types
with high antibody prevalence tended to be M strains and types with low antibody
prevalence were H strains.
Studies of rhinovirus antibody prevalence in specimens from many different parts
of the world have shown that rhinoviruses have a worldwide distribution (160).
Broadly speaking, there are differences in prevalence of antibody between countries
for any particular virus tested. Rhinovirus antibody prevalence in tropical areas is
equal to orgreater than that in the temperate zone.
3. Seasonal Distribution ofInfections
In an early epidemiologic study of acute respiratory disease in which virologic
methods were not available, Frost et al. noted that . . . "During the season ofhigh
prevalence, from September to March, inclusive, the incidence curve (for colds) in
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FIG. 3. Total and rhinovirus respiratory illness rates (i 1.7 standard deviations) in young adults. Data
collected over a 6-year period [1963-1969]. (Adapted from Gwaltney et al. (62).)
each locality exhibited a series ofoscillations, constituting a succession ofepidemics,
each of several weeks' duration, rather irregular in sequence and magnitude, but
clearly not attributable to mere chance fluctuation (57)." The data from this study
showed that one ofthe recurrent epidemic peaks ofcolds occurred in the early fall,
usually in September. Later in the Cleveland family study of minor illness, a Sep-
tember peak of colds was a prominent feature ofthe seasonal pattern ofillness, al-
though no respiratory viruses could be associated with this period (36). Newer
studies using virus cultures have now shown that rhinoviruses account for a major
part of this early fall outbreak of colds which annually initiates the respiratory
disease season (Fig. 3) (62,114). In a study ofadults with colds in the eastern United
States, rhinovirus infection rates reached their highest annual point (3.5 illnesses/
1000/day; 1.28 per person-year) in September. At this time, rhinoviruses accounted
for approximately 40% of all colds and greater than 90% of diagnosed colds.
Rhinovirus infection rates fell and remained low (1-1.5/1000/day) in the winter and
early spring. A second peak of rhinovirus illness occurred in April and May. Al-
though total respiratory rates were falling in the spring, rhinoviruses were
associated with a substantial fraction of all colds. Throughout the summer
rhinovirus colds continued to account for an important part of total acute respira-
tory disease, although respiratory illness rates reach theirlowest point at this time.
In the tropics the respiratory disease season coincides with the rainy season, be-
ginning in May and June and ending in November and December (118). Most
rhinovirus infections occur during the rainy season, (117) but more precise moni-
toring of the seasonal prevalence ofrhinovirus colds has not been done. In arctic lo-
cations, where the respiratory disease season coincides with cold weather as in
temperate climates, rhinovirus outbreaks have been observed but precise patterns
have not been studied (171).
Although there is a well established correlation between the lowered temperatures
of fall, winter, and spring months and the increased occurrence ofacute respiratory
disease during that period (83), there is no evidence to support a direct causal rela-
tionship between thermal cold and increased rates of infection. As to meterologic
effects specifically on rhinovirus infections, a thorough study of weather and colds
showed that none ofnine weather variables including temperature had adistribution
remotely resembling the autumn (presumed rhinovirus) peak ofcolds (98). This is in
keeping with the observations from two long-term studies ofrhinovirus infections in
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which prominent September peaks of rhinovirus colds were associated with mild
seasonal fall weather and not with the more severe cold of winter which requires
heating ofhomes and alterations in living patterns (76,116). More direct evidence on
this question comes from a volunteer study with rhinovirus type 15 in which ex-
posure to thermal cold showed no adverse effect on susceptibility to experimental in-
fection or severity ofillness (46).
The reason for seasonal variation in the incidence of colds remains a mystery.
Speculations include the idea that climatic conditions, which lead to crowding in-
doors, provide better conditions for virus spread (84). Also, school openings in the
fall bring together into large groups a segment of the population highly susceptible
to rhinoviruses and other respiratory viruses. Therehas also been speculation on the
effect of weather changes on virus infectivity and host resistance. Changes in hu-
midity have been shown to influence the survival of respiratory viruses and seasonal
changes may affect hormonal functions in man that influence susceptibility to in-
fection (164). In this regard, female volunteers were found to be more susceptible to
experimental colds in the middle third than during other times in the menstrual
cycle; possibly because ofhormonal effects on nasal mucosa (48).
4. Distribution ofSerotypes
Tabulation of the isolation of rhinovirus serotypes in the United States based on
published studies revealed wide dispersal of most types throughout the country (68).
Of the first 55 numbered types, only type 5, an English strain, had not been
recovered in the United States. The serologic survey cited earlier (72) showed anti-
body to type 5 virus in sera from U.S. populations. Thus, the conclusion that
rhinovirus types are widely distributed throughout the United States and the world
is supported by both virus isolation and serologic data.
The current impression, based on longitudinal studies, is that multiple types circu-
late in a geographic area at any given time with no discernible pattern to their ap-
pearance or reappearance (64,68). Over several years, some types were endemic
while others appeared only once or twice. It has been proposed, however, that
certain rhinovirus types might possess a higher degree ofinfectivity than others, in-
creasing their importance as a cause ofcolds and making them primecandidates for
inclusion in vaccines (115). Analysis of the frequency of isolation of the various
rhinovirus types, however, does not show a sharp division between "common" and
"uncommon" types. Also, types most commonly encountered in one study have not
necessarily been the same as those in other studies. From the analysis of combined
data from several studies, it was not possible to designate a particular year as a na-
tionwide epidemic year for a particular type nor was it possible to detect pathways
ofrhinovirus transmission by types across the country (68).
One general pattern of serotype distribution has emerged which raises a basic
question about the antigenic nature ofrhinoviruses. Long-term studies have shown a
gradual change with time in the overall distribution of serotypes in a given
geographic location (14). Serotypes with lower numers, which in general were dis-
covered earlier, have been replaced by higher numbered, "newer" types and strains
which are untypable with available antisera. The reason for the shift in types is un-
known; one possibility is that all of a very large number of stable antigenic types
have not cycled through the locations where rhinovirus surveillance is in progress
and have not been discovered. Another possibility is that rhinoviruses are under-
going antigenic drift. If this is occurring with sufficient speed to result in marked
changes in the already numbered viruses, they could be mistaken for "new" types.
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Bearing on the second possibility are two studies showing antigenic differences be-
tween strains of the same types isolated several years apart (146,157). In one
instance the newer strain had broader antigenicity than the prototype.
B. Occurrence in Different Settings
1. Family
One ofthe major sites ofrhinovirus spread in civilian populations is thehome (35,
71,113). The characteristic epidemiologic pattern in this setting is for a school child
to introduce virus into the home after which transmission occurs to other members
ofthe family (Fig. 4). Secondary infections are most common in young children and
mothers, but all members of the household including fathers, other adults working
outside the home, and adolescents are affected. Two to five day intervals are com-
monly seen between onsets ofcases.
In one study, total respiratory illness rates were highest in preschool children (77).
Rates in housewives were similar to those in school children and were consistently
higher than in adults working outside the home. During the height of the epidemic,
the frequency of rhinovirus infection as determined by culture and serology was
similar in all age groups. Later, in October, total illness rates were seen to decline in
adults and older children while young children continued to have frequent colds for
which no etiology could be established. The presence of children in the home was
associated with total respiratory illness infection rates in adults which were higher
than for adults who did not have this exposure. At theheight ofa September peak of
illness, rhinovirus respiratory illness rates for all family members, adults and
children, were approximately 8/1000/day (2.92 per person-year), calculated on the
basis ofrhinovirus causing 40% offall colds.
In one family study, the rhinovirus attack rate for two epidemic types was 25 and
50% (35) while the attack rate for type 16 in an outbreak in families in a small
Alaskan community was nearly 70% (171). In another study, the secondary attack
rates for members of families into which a rhinovirus had been introduced were in-
versely proportional to preexposure serum antibody levels; 71, 50, and 21% of
persons with titers of <2, 4, and 8-32, respectively were infected (75,77). Based on
ANTIBODY TO
RV 40
ACUTE/CONV.
WORKING RV 40
ADULT (Father) <2-8
WORKING 8 8
ADULT (Mother) -
HIGH SCHOOL RV 40
CHILD 2-_<2-
JUNIOR RV 40
HIGH SCHOOL <2-32
CHILD
GRAMMAR
SCHOOL <4-16
CHILD
8/28 9/4 9/11 9/18 9/25
FIG. 4. A family outbreak of colds due to rhinovirus type 40. Black bars represent periods of sympto-
matic illness. RV 40 represents positive virus culture. The diagnosis of rhinovirus infection in the index
case [grammar school child] was made by serology. (Adapted from Hendley et al. (75).)
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the results of a study of colds in the tropics (113), the secondary attack rate with
type 39 was calculated to be 56% in antibody-free persons (75).
2. Schools
A key study has shown that rhinoviruses spread efficiently among children in
nursery school (4) thus establishing transmission in school as an important step in
rhinovirus dissemination in civilian populations. Spread of some types in the school
room was extensive, involving up to 77% ofchildren. However, halfofthe serotypes
introduced into the groups showed no evidence ofspread. The reason for the lack of
spread of some types is unknown, but the authors concluded that it was not due to
characteristics of the associated illness, patterns of viral shedding, or levels of im-
munity. Spread was most pronounced during March and April, a recognized time of
increased prevalence of rhinovirus colds. The study unfortunately did not extend
through the September peak ofrhinovirus infections.
Rhinovirus activity has been observed in day school groups at various grade levels
(127) and in boarding school, university, and medical school populations (66,69,91,
111,132). Rhinoviruses are a prominent cause ofmorbidity in thesegroups, although
information on their specific epidemiologic behavior is not available. Presumably,
spread in older children, adolescents, and young adults who are part ofclosed popu-
lations such as boarding schools occurs between roommates, friends, athletic teams,
etc.
3. Military
Rhinoviruses account for a large amount of the morbidity associated with upper
respiratory tract infections in military populations (54,86,111). In a prospective
study of Navy and Marine recruits, 90% of the men developed rhinovirus infection
during a 28-day period in basic training, giving an attack rate for this period of 11.7
per person-year (141)! Seventy-five percent of the infections occurred within the
first two weeks of training, and simultaneous or closely spaced infections with two
different serotypes in the same man were common. Although a prominence ofsome
M serotypes has been noted in military populations, the epidemiologic behavior of
the numbered rhinoviruses is generally similar to that in civilians, showing a
constantly changing mosaic ofprevalent types (121).
VI. MECHANISMS AND ROUTE OF TRANSMISSION
The exact mechanism by which rhinoviruses are passed from person to person is
unknown. In civilian populations, as discussed above, school children are a very im-
portant reservior of the virus; home and school are the place where spread most
often occurs. These facts alone, which indicate that conditions of personal contact
are necessary for efficient rhinovirus transmission, suggest that spread is most often
by some type ofshort range exposure to infectious secretions. Thepossibility oftrue
airborne transmission ofrhinovirus in droplet nuclei formed from respiratory secre-
tions is not excluded by these findings, however. Information on the various steps in
the sequence of transmission is best evaluated in relation to the question of spread
by direct manual contact with infectious secretions versus spread by contact with
virus in contaminated aerosols ofvarious particle size.
Viral shedding, the first step in the sequence, occurs primarily from the nose.
Under experimental conditions, the amount of rhinovirus in the nasopharyngeal
washes ofvolunteers peaked (832 TCID50/ml) on the third day after inoculation and
then fell to low levels which persisted for up to two weeks (42). Some volunteers
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showed a different pattern of nasal shedding which was characterized by delayed
onset and slow build up over seven days to relatively low maximum virus concentra-
tions (41 TCID,0/ml). Comparisons of rhinovirus concentrations in respiratory
secretions from individuals with natural colds have shown that the quantity ofvirus
in nasal mucus tends to be 10 to 100 fold greater than in pharyngeal secretions (78).
Also, virus was present only 50% ofthe time in saliva where it was found in low con-
centrations. In keeping with the relative scarcity of rhinovirus in saliva was the
finding that virus was infrequently recovered from simulated coughs and sneezes.
The relatively poor yield of virus in saliva can be interpreted as evidence against
spread through the air, since aerosols produced by coughing and sneezing are mainly
of oral origin, coming primarily from the pool of saliva in the anterior part of the
mouth (7,85). On the other hand, the idea ofnasal mucus as adirect source oftrans-
missible virus is appealing because ofthe relatively high titers ofvirus in mucus and
the great potential for people with colds to contaminate the environment, including
fingers, with this substance. Rhinovirus has been recovered from the hands of ap-
proximately 50% of adults with natural (78) and experimental colds (131). In-
formation obtained on the second step in transmission, virus survival in the environ-
ment, indicates that rhinovirus in concentrations found in nasal mucus survives
regularly for up to 3 hr on skin and avariety ofsurfaces, such as wood, plastic, steel,
Formica, and hard fabrics (78).
Some evidence in favor of spread through the air comes from experiments in
which biological tracers, the spores of Bacillus mycoides, were placed in the nose.
These experiments showed that blowing the nose and especially sneezing could
produce droplets containing the tracer which were small enough to remain airborne
and yet in the size range (3-16,) that is likely to be trapped in the nose (10). Experi-
mental evidence on the duration ofsurvival ofrhinovirus in particles suspended in air
is not available.
To complete the sequence ofevents leading to successful spread, virus must reach
an appropriate portal of entry. Under experimental conditions, small quantities of
rhinovirus (the human infectious dose50 = 0.032 to 0.75 tissue culture infectious
dose50) placed in the nose in coarse drops will efficiently initiate infection (39). There
is indirect evidence that similar small amounts ofvirus may initiate infection under
natural conditions (75). Experimental infections have been produced by the inha-
lation of rhinovirus aerosols with particle sizes in the true droplet nuclei range (0.3-
2.5,u) but required approximately 20 fold greater concentrations of virus than
intranasal challenge. Thus, it appears that the nasal mucosa is more susceptible to
rhinovirus than is the lower respiratory tract (28). In this experiment, it was not
possible to exclude the possibility that infection resulted from that fraction of the
viral aerosol which was deposited in the nose rather than that reaching the lower
respiratory tract. Experimental rhinovirus colds have also been produced by drop-
ping small amounts of virus on the conjunctiva (78), indicating that the eye is
another portal of entry for rhinovirus. In contrast, rhinovirus placed in the mouth
does not readily initiate infection (13,78). In related experiments in which infected
and susceptible volunteers kissed under controlled conditions, oral contact was an
inefficient method ofcausing spread (131).
From the results of the above work, it appears that rhinovirus must reach the
nasal or perhaps the conjunctival mucosa for efficient initiation of infection. Ob-
servations have been carried out on adults in medical conferences and in Sunday
School which show that normal behavior includes placing fingers into the nose or
onto the conjunctiva with regularity (78). Episodes in which finger contact with nasal
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TABLE 3
Postulates to Test an Hypothesis of Microbial Transmission
1. Infectious microorganism must be produced in infected host at proposed anatomic source
2. It must be present in secretions or tissues which are shed from host by proposed route
3. It must be present and survive in or on the appropriate environmental substance or object
4. The contaminated environmental substance or object must reach the proposed portal of entry
5. Interruption of transmission by the hypothesized route must prevent spread of infection
and conjunctival mucosa occurred were measured on the average of two per three
person-hours of observation. This type of behavior provides sufficient opportunity
for accidental self-inoculation if the fingers are contaminated with virus. The al-
ternative method of spread, transmission via airborne particles with deposition in
the respiratory tract, is also feasible. The average adult is effectively exposed by
inhalation to large amounts (approximately 10 liters per min) of air, thus, small con-
centrations ofvirus in the air may be sufficient to transmit infection.
Direct evidence on the relative importance of these different methods of spread is
limited to studies of experimental infections. In one volunteer experiment in closed
barracks, airborne transmission of rhinovirus did not occur across a wire mesh bar-
rier from infected to susceptible volunteers (39). In another study, infected volun-
teers failed to spread rhinovirus to susceptible subjects confined in the same closed
room by singing and other activities designed to create infectious aerosols (32). On
the other hand, self-inoculation of the nose and eye with virus transmitted on the
finger from a previously contaminated site has been successful in initiating experi-
mental infection (78). The sum of evidence, particularly the frequent finding of
rhinovirus on the hands and its relative scarcity in secretions from simulated coughs
and sneezes, suggests that manual contact with nasal mucus may be the more im-
portant mode of spread. It is possible, however, that more than one method
contributes to rhinovirus dispersal under natural conditions. To find a more definite
answer to this question, it will be necessary to satisfy several postulates which in-
clude a requirement for proofthat interruption of spread by the hypothesized route
results in a reduction in natural infections (Table 3).
VIII. PATHOGENESIS
The acute stage of viral rhinitis is characterized by hyperemia and edema of the
mucous membrane with exudation of serous and mucinous fluid (140). The nasal ca-
vities are narrowed by thickening of the membrane and engorgement of the tur-
binates. Histologically, there is marked edema of subepithelial connective tissue
with sparse infiltration of neutrophils, lymphocytes, plasma cells, and eosinophils.
The secretory activity ofthe mucous-secreting submucosal glands is increased.
Specific work on the gross and histologic findings in acute rhinovirus infections is
limited. In one study, nasal biopsies were obtained by curettage from volunteers
with experimental rhinovirus infection (40). Fixed smears stained by the Pa-
panicolaou technique showed no consistent changes associated with either infection
or illness. In another investigation, scanning electron microscopy was used to
examine bovine tracheal organ cultures infected with a bovine rhinovirus (Fig. 5)
(137). Characteristic changes were seen in infected cultures which consisted of ex-
trusion ofdegenerating ciliated and nonciliated cells and relatively smooth areas of
denuded epithelium. If similar anatomic abnormalities occur in human rhinovirus
infections, they could explain the depressions in nasal mucociliary flow rates which
have been observed in volunteers with experimental infection (145).
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FIG. 5. Organ cultures of bovine tracheal epithelium. A. Uninfected control culture. Field width, 100
Mm. B. Culture infected with bovine rhinovirus, fixed six days after inoculation. E, extruding ciliated cells.
G, extruding goblet cells. Field width, 180 ,m. (Reprinted by permission ofthe authors and the Editor of
the Amer. Soc.for Micro.; Reed and Boyde (137).)
The mechanism by which rhinovirus produces disease is unknown, but in-
formation on the correlation of peak virus titers and illness onsets suggests that an
important mechanism may be direct cell injury secondary to the cycle of virus
replication (39,42). In experimental rhinovirus infection, virus may be recovered
from nasopharyngeal wash in small amounts by 24 hr after inoculation. Virus con-
centrations then rise rapidly to peak values on days two and three. Maximal virus
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shedding is followed within 24 hr by the release of large quantities of protein from
the mucous membrane. The incubation period is usually two to four days and the
onset of illness is very closely related to the time of peak virus shedding. At this
time, nasal epithelial cell biopsies are uniformly positive for virus; later when lesser
amounts ofvirus are shed, they are only occasionally positive (39,40).
The anatomic limits of rhinovirus infection have not been determined. Com-
parisons ofvirus concentrations recovered from the nose, throat, saliva, coughs, and
sneezes, discussed above, suggest that the major site of infection is the nose. It is
currently unknown whether virus which is recovered from the pharynx and saliva is
produced in these sites or merely represents contamination with nasal secretions.
There is also no direct evidence, such as might be obtained with transtracheal as-
piration or lung puncture, on whether rhinovirus invades the lower respiratory tract.
There have been multiple reports of rhinovirus infection in patients, especially
children with disease of the lower respiratory tract (21,31,58,130), although the
possibility cannot be excluded that concurrent infection with other viral or bacterial
pathogens may have been present and caused the illness which was seen. The opinion
of several workers in the field is that rhinoviruses are not an important cause of
serious acute lower respiratory tract disease in children (6,67,122,134,171).
As will be discussed below, there is mounting evidence that rhinovirus infections
are associated with periods ofacute exacerbation in patients with chronic bronchitis.
Also, recent work has associated rhinovirus infections with pulmonary function ab-
normalities in patients with chronic bronchitis (152), cigarette smokers (56), and
healthy adults (5,18). The mechanism by which rhinovirus infection might alter
pulmonary function is unknown. Direct invasion of the lower respiratory tract by
the virus in a compromised host is a possibility, but reflex mechanisms or secondary
bacterial infection might also play a role. Indirect evidence against viral invasion of
the lower respiratory tract includes the finding that experimental rhinovirus in-
fection produced by inhalation of small particle aerosol in normal persons charac-
teristically produced the clinical picture of an upper respiratory tract illness (28).
Also, the fact that rhinovirus grows relatively poorly at the core body temperature
of 370C is against the possibility that rhinovirus frequently invades the lower
respiratory tract.
VIII. IMMUNITY
Work on the immunology of rhinovirus infections has focused on humoral im-
munity, particularly the role ofantibody in respiratory secretions. No information is
available on the role, if any, of cellular immunity in resistance to rhinovirus in-
fection.
Serum neutralizing antibody titers rise in up to 75-80% ofpersons with natural or
experimental rhinovirus colds (15,63,65,77). The level of serum neutralizing anti-
body prior to natural or experimental challenge is inversely proportional to the sub-
sequent infection rate. Under conditions of exposure to rhinovirus in the home,
naturally acquired serum antibody at a level of8 was associated with a sharp reduc-
tion in the infection rate, and serum antibody levels of > 16 were associated with
solid immunity (77). With artificial challenge it is possible to infect volunteers, al-
though at a reduced rate, who have higher titers of naturally acquired serum anti-
body. In one study using relatively small challenge doses ofvirus (0.05-50 TCID50),
no infections occurred in volunteers with prechallenge titers of >64 (75). In other
studies in which the infecting inocula contained more virus (17-10,000 TCID5O), in-
fections were observed in volunteers with prechallenge titers of up to 512, pre-
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sumably as a result ofoverwhelming normal immunity by an artificially large virus
challenge (19,123).
The above findings do not necessarily indicate that serum neutralizing antibody is
the primary immune mechanism responsible for resistance to rhinovirus, since
naturally acquired serum antibody is found in close association with antibody in
nasal secretions (123,129). The ratio of nasal secretion to serum neutralizing anti-
body appears to be higher (approximately 1:2) after recent than after remote (ap-
proximately 1:16) infection, suggesting a decline in nasal secretion antibody with
time (19).
Several attempts have been made to determine the relative importance and
specific roles ofserum and nasal secretion antibody in protection against rhinovirus
infection. Naturally acquired antibody in nasal wash specimens and serum was
associated with resistance to "infection" ifpresent in sufficient titer before artificial
challenge, but it did not appear to modify "illness" or virus shedding (19). Because
of the close association of naturally acquired antibody in serum and nasal secre-
tions, the findings of this study did not answer the questions posed. Another ap-
proach to theproblem was to administer inactivated rhinovirus vaccine by either the
parenteral or intranasal route to selectively elicit nasal secretion and/or serum anti-
body. Vaccinegiven intranasally in large amounts led to the production ofantibody
in both serum andnasal secretions whileparenteral vaccination resulted primarily in
serum antibody production (128,129). Intranasal challenge with rhinovirus at a later
date resulted in the reduction of "illness" and virus shedding only in volunteers who
received the intranasal vaccine(1 1,128,129). In these studies, intranasal vaccination
was not associated with a clear cut reduction in "infection" rate determined by anti-
body response. Therefore, this work suggested that the primary effect of nasal anti-
body was to modify "illness" and reduceviral shedding. This conclusion is inconflict
with that oftheinvestigation cited above(19) and ofother reports which have found
that the major effect of humoral (serum) immunity was prevention of"infection"
and not modification ofillness(42,76,77,123). Other studies have reported on finding
an association between naturally acquired (63) and vaccine induced (44) serum anti-
body and reduction of"illness" and, in the latter study(118), diminished virus shed-
ding. Thus, currently available data on the mechanism of action of the nasal and
serum components ofhumoralimmunity to rhinovirus infection are not in complete
agreement; further work isnecessary toprovide aclear understanding ofthis area.
Naturally acquired neutralizing activity against rhinovirus in serum has been
found to sediment primarily in the 5S to 7S region and to be associated with frac-
tions containing IgA and IgG (19,142). After recent experimentally-induced
rhinovirus infection or intranasal vaccination with inactivated rhinovirus vaccine,
neutralizingactivity has also been associated with 19SIgM (19,94,142).
Under normal conditions, nasal secretions contain 12 different identifiable pro-
teins found in serum as well as six antigenic components not present in serum (143).
Secretory IgA, the most abundant protein in nasal secretions, is synthesized locally
at sites adjacent to the mucosa and accounts for 30% or more of total protein in
nasal secretions. Rhinovirus neutralizing activity in nasal secretions is associated
primarily with IgA in 9S tollS fractions, although secretory IgA is not entirely
homogenous in its sedimentation characteristics, being found also in 7S and 19S
regions (94). The symptomatic period of rhinovirus illness is associated with
considerable transudation of serum proteins, including IgG, into nasal secretions
(12,143). After cessation of illness, the concentration of serum proteins in nasal
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secretions falls rapidly; at this time the IgA concentration begins a progressive sus-
tained increase. The IgA which appears during this period is not associated with an
increase in specific neutralizing activity for the infecting virus. Specific neutralizing
antibody first appears in nasal secretions and serum at approximately 2 wk in volun-
teers lacking detectable antibody. Antibody concentrations increase most rapidly
between the third and fourth weeks, by which time viral shedding is completed.
Volunteers with preexisting serum antibody may show rises in nasal antibody titers
by as early as day 7. Neutralizing antibody to rhinovirus has also been found in tears
and parotid saliva where it is associated with the IgA fraction (47).
Because of the sequence of events described above, it is felt that recovery from
rhinovirus infection and illness is not dependent on humoral immunity (19). It has
been shown that interferon is released into respiratory secretions during the course
of experimental rhinovirus infection. This led to the suggestion that in rhinovirus
colds, as in other viral infections, interferon may have an important role in recovery
(16). Also, resistance to experimental rhinovirus infection has been shown to be
associated with a non-specific mechanism of unknown nature which occurs as a re-
sult of recent infection with a heterologous rhinovirus type (52). However, in epide-
miologic studies of nursery school children (4) and military recruits (141) many
instances of closely spaced rhinovirus infections have been seen, raising the question
ofhow important this non-specific resistance is in natural infection.
IX. PATTERNS OF HOST RESPONSE
A. Clinical Features
Rhinoviruses produce a typical common cold characterized by rhinorrhea, nasal
obstruction, sneezing, pharyngeal discomfort, and cough. The median length of
natural illness in young adults is seven days with peak symptomatology occurring on
the second and third day of illness (63). Symptoms last up to 2 wk in one-quarter of
cases and may be prolonged to 1 mo, although secondary bacterial infection may
play a role when this occurs. The profile of rhinovirus illness can be distinguished
from influenza by the relative severity of systemic complaints and cough with
influenza (Fig. 6). Rhinovirus colds differ from group A Beta hemolytic streptococ-
cal pharyngitis in having more nasal involvement and cough and less severe and
prolonged pharyngeal discomfort. This information unfortunately is oflimited value
to the clinician. In the individual patient it is impossible to distinguish, on clinical
grounds, rhinovirus colds from those caused by other common respiratory viruses.
In children, rhinovirus also produce the common cold syndrome (6,139). Whether
rhinoviruses cause more serious disease in children, such as viral pneumonia, croup
and bronchiolitis, is still not clear. As discussed in the section on "Pathogenesis,"
the prevailing opinion is that rhinoviruses, unlike parainfluenza viruses and respira-
tory syncytial virus, do not commonly cause serious disease ofthe lower respiratory
tract and do not produce more severe illness in children than in adults.
Cough is a prominent feature of rhinovirus colds in patients of all ages, indicating
that involvement of the lower respiratory tract of some type does occur. The fre-
quency and duration of cough is markedly increased in cigarette smokers, particu-
larly females, with rhinovirus colds (63). Also, it has been reported that up to 40% of
exacerbations in patients with chronic bronchitis may be associated with rhinovirus
infections (49,104,153). In patients with chronic bronchitis, worsening of forced
expiratory vital capacity has persisted for up to 6 mo following rhinovirus infection
(152).
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FIG. 6. Comparison of symptom profiles of rhinovirus colds [139 cases] type A2 influenza [33 cases] and
group A Beta hemolytic streptococcal pharyngitis [17 cases]. (Adapted from Gwaltney et al. (63).)
It has also been suggested that rhinovirus infections may precipitate asthmatic at-
tacks in children (81,109). Asthmatic children have been found to experience a
significantly greater number of viral respiratory infections, primarily due to
rhinoviruses, than do non-asthmatic controls (108). These recent findings are ofin-
terest in view of an earlier report that volunteers with a history of allergy have
enhanced susceptibility to experimental colds (84).
During acute rhinovirus illness in volunteers, there is a modest increase in total
blood leukocyte counts due to an increase in circulating neutrophiles (15). Later in
the infection, moderate elevations in the erythrocyte sedimentation rate may occur.
The diagnosis of rhinovirus infection is best accomplished by isolation of the virus
from nose and throat swab or nasal wash specimens. There is currently very limited
availability of facilities for the laboratory diagnosis of rhinovirus infections in
routine medical practice (130).
B. Apparent-Inapparent Infection Ratio
Data based on virus isolations are available from several studies for calculating
apparent-inapparent infection rates for rhinoviruses. The results, which are in good
agreement, indicate that the majority of rhinovirus infections are associated with
symptomatic respiratory illness. The percentages of rhinovirus infections associated
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with illness were 78% in families (55), 88% in medical students (55,69), 69% in in-
surance company employees (62), and 70-74% in military trainees (55,86,121).
Thus, the ratio ofapparent to inapparent infections is approximately three to one.
X. CONTROL AND PREVENTION
Methods are not available for controlling or preventing rhinovirus infections.
Studies with experimental monovalent rhinovirus vaccines given parenterally have
met with only partial success. Rhinovirus antigens areinferior to poliovirus antigens
for vaccine production. In volunteers, parenteral vaccination has been followed by
reduction in illness and virus shedding but not infection (2,44,123). It is difficult to
evaluate studies of parenteral vaccine efficacy under natural conditions because of
the multiplicity ofserotypes (110,136).
The discovery of ever increasing numbers of apparently highly specific antigenic
types has led to pessimism over the prospects ofdeveloping vaccines with practical
value (154). One piece ofinformation which indicates that thereis still somehope for
the eventual development of rhinovirus vaccines ofpractical value is the recent dis-
covery of antigenic relationships among some ofthe numbered rhinoviruses (27). In
this work, done in rabbits, potent monovalent rhinovirus antigens were successfully
used to stimulate heterotypic antibody responses to one or moredifferent types.
The problem of vaccine development is further complicated by the findings dis-
cussed above under "Immunity," which indicate an important role for secretory an-
tibody in resistance to rhinovirus infection. Parenteral vaccination does not appear
to be an efficient means of stimulating rhinovirus neutralizing antibody in nasal
secretions, suggesting that immunization via the respiratory tract may be necessary
for optimal protection. This has led to interest in the development ofvaccines pre-
pared with live attenuated strains ofrhinovirus (43).
Control of rhinovirus infection by chemoprophylaxis has also been under inves-
tigation. In early work, rhinoviruses were found to be susceptible to 2-(a-
hydroxybenzyl)-benzimidazole and related compounds which have specific actions
on virus replication (147,158). Since then a number ofothercompounds with activity
against rhinoviruses in vitro have been discovered (60,102,138,149,151). Compounds
with antirhinovirus activity which have been tested in vivo have not been effective,
however (138,150,163). Interferon and interferon inducing agents have also received
clinical trials with experimental rhinovirus infection (80,107,124). Theultimatevalue
ofthis approach is still uncertain, but one of the studies yielded encouraging results
(124).
In recent years, a controversy has arisen over the proposal that large doses ofvi-
tamin C be used for the prophylaxis and treatment of common colds (125). Con-
trolled trials ofthe efficacy of one and 2 g per day ofvitamin C in the prevention of
natural colds ofundetermined etiology showed an approximately 30% reduction of
days of disability or morbidity among volunteers taking this compound (3,29). On
the other hand, 3 g per day ofvitamin C did not prevent experimental rhinovirus in-
fections in volunteers and had at most an unimpressive reduction in theillness scores
of prophylaxed subjects over those of controls (148,169). Thus, while vitamin C
taken prophylactically may have some beneficial effect on the frequency and/or
severity of the symptoms of natural colds, the magnitude of this effect does not
seem sufficient at present tojustify a recommendation for the general prophylactic
use oflarge doses ofthe compound. There is no proofofthe specific effectiveness of
vitamin C against rhinovirus infections.
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Rhinovirus colds might also be controlled ifways arediscovered to interrupt their
spread from person-to-person. The development ofenvironmental control measures
is largely dependent on precise knowledge ofthe mechanism of rhinovirus spread. If
accidental self-inoculation of the nose or eye with virus contaminating the fingers is
of importance, then the simple expedients of avoiding finger contact with the nose
and eyes and of hand washing, particularly when a household member develops a
cold, may be beneficial in reducing the risk ofinfection.
XI. UNRESOLVED PROBLEMS
A number of important questions concerning rhinoviruses remain unanswered.
These include: the number ofvirus serotypes and their antigenic stability; the extent
of antigenic relatedness; the mechanisms by which rhinoviruses produce disease and
stimulate host immunity; their mode of transmission; and finally, the biochemical
nature of the virus, particularly as it relates to the action ofantivirals with potential
clinical usefulness. The answers to these questions may have a direct effect on the
success of solving the overriding practical problem, which is the development of
methods for rhinovirus control. The increasing awareness of the importance of
rhinoviruses, not only as a major cause ofthe morbidity ofcommon colds and their
complications, but also as precipitants of more serious illness such as chronic bron-
chitis and asthma should stimulate increasing effort to understand rhinovirus be-
havior.
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